United States (US) Antipsychotic Drugs Market (2025-2031) | Value, Growth, Outlook, Trends, Size & Revenue, Forecast, Competitive Landscape, Share, Segmentation, Analysis, Companies, Industry

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Antipsychotic Drugs Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Antipsychotic Drugs Market - Industry Life Cycle

3.4 United States (US) Antipsychotic Drugs Market - Porter's Five Forces

3.5 United States (US) Antipsychotic Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.6 United States (US) Antipsychotic Drugs Market Revenues & Volume Share, By Application, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of mental health disorders in the US

4.2.2 Technological advancements leading to the development of more effective antipsychotic drugs

4.2.3 Growing awareness and acceptance of mental health treatment in society

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for approval and marketing of antipsychotic drugs

4.3.2 High cost associated with research and development of new antipsychotic medications

4.3.3 Side effects and safety concerns associated with some antipsychotic drugs

6.1 United States (US) Antipsychotic Drugs Market, By Drug Class

6.1.1 Overview and Analysis

6.1.2 United States (US) Antipsychotic Drugs Market Revenues & Volume, By Drug Class, 2021- 2031F

6.1.3 United States (US) Antipsychotic Drugs Market Revenues & Volume, By First Generation, 2021- 2031F

6.1.4 United States (US) Antipsychotic Drugs Market Revenues & Volume, By Second Generation, 2021- 2031F

6.1.5 United States (US) Antipsychotic Drugs Market Revenues & Volume, By Third Generation, 2021- 2031F

6.2 United States (US) Antipsychotic Drugs Market, By Application

6.2.1 Overview and Analysis

6.2.2 United States (US) Antipsychotic Drugs Market Revenues & Volume, By Schizophrenia, 2021- 2031F

6.2.3 United States (US) Antipsychotic Drugs Market Revenues & Volume, By Bipolar disorder, 2021- 2031F

6.2.4 United States (US) Antipsychotic Drugs Market Revenues & Volume, By Unipolar depression, 2021- 2031F

6.2.5 United States (US) Antipsychotic Drugs Market Revenues & Volume, By Dementia, 2021- 2031F

6.2.6 United States (US) Antipsychotic Drugs Market Revenues & Volume, By Others, 2021- 2031F

7.1 United States (US) Antipsychotic Drugs Market Export to Major Countries

7.2 United States (US) Antipsychotic Drugs Market Imports from Major Countries

8.1 Patient adherence rates to antipsychotic drug regimens

8.2 Rate of adoption of new antipsychotic medications in the US market

8.3 Number of clinical trials for antipsychotic drugs conducted in the US

8.4 Prescription rates for antipsychotic drugs compared to other mental health treatments

8.5 Number of healthcare providers specializing in mental health prescribing antipsychotic drugs

9.1 United States (US) Antipsychotic Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.2 United States (US) Antipsychotic Drugs Market Opportunity Assessment, By Application, 2021 & 2031F

10.1 United States (US) Antipsychotic Drugs Market Revenue Share, By Companies, 2024

10.2 United States (US) Antipsychotic Drugs Market Competitive Benchmarking, By Operating and Technical Parameters